| MELVILLE, N.Y., Sept. 2, 2021 /PRNewswire/ -- American Regent, Inc. introduces FDA-approved Multrys (trace elements injection 4*, USP). Multrys is indicated in neonatal and pediatric patients weighing less than 10 kg as a source of zinc, copper, manganese, and selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.2 View more product specific information. "We are pleased to offer another FDA-approved multiple trace elements injection specifically developed to more closely align with the American Society for Parenteral and Enteral Nutrition (ASPEN) recommendations for trace element supplementation than previously marketed products.3 This new formulation, which is manufactured in America, has been designed to meet the special needs of the neonatal and pediatric patient population and is part of our overall initiative to retire our line of marketed unapproved trace element products," stated Joann Gioia, Vice President and Chief Commercial Officer at American Regent, Inc. "The launch of Multrys demonstrates American Regent's continued commitment to addressing the needs of patients who require trace element supplementation." This product is available for immediate shipment. Customers can order Multrys through their wholesaler/distributor, or by contacting our Customer Support Group at 1-800-645-1706. Multrys (trace elements injection 4*, USP) is supplied as follows:
|
Read Full Story: https://www.biospace.com/article/releases/american-regent-launches-multrys-trace-elements-injection-4-usp-/
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.